Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dapsone in rosacea fulminans.

G Bormann1, G Gaber, M Fischer

  • 1Department of Dermatology and Venerology, Martin-Luther-University Halle-Wittenberg, (Saale), Germany. gisela.bormann@medizin.uni-halle.de

Journal of the European Academy of Dermatology and Venereology : JEADV
|January 5, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Overlap of acute generalized exanthematous pustulosis and toxic epidermal necrolysis: response to antitumour necrosis factor-alpha antibody infliximab: report of three cases.

Journal of the European Academy of Dermatology and Venereology : JEADV·2007
Same author

Concomitant traumas influence prognosis in melanomas of the nail apparatus.

The British journal of dermatology·2006
Same author

[Nodules of the scalp and body folds].

Annales de dermatologie et de venereologie·2004
Same author

[Sporotrichoid atypical mycobacterial infections. Antibiotic monotherapy].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2004
Same author

[American cutaneous leishmaniasis: special features in diagnosis and therapy].

Deutsche medizinische Wochenschrift (1946)·2003
Same author

[Arteriovenous fistula: an uncommon cause of leg ulcers].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2002
Same journal

Environmental criteria in dermatology research grants.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026
Same journal

Microneedling with adipose MSC exosomes versus monotherapy for androgenetic alopecia.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026
Same journal

Diabetes and melanoma: Impact on prognosis and healthcare costs.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026
Same journal

Differential survival with adjuvant immunotherapy in stage III acral versus non-acral melanoma.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026
Same journal

Estimating the global burden of mental health disorders associated with atopic dermatitis.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026
Same journal

Proteomic analysis in hidradenitis suppurativa reveals systemic inflammation in all disease stages.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026
See all related articles

Rosacea fulminans, a rare facial condition, typically requires systemic glucocorticoids and isotretinoin. This case study highlights dapsone as an effective alternative treatment, achieving complete healing in five weeks for a patient unresponsive to conventional therapies.

Area of Science:

  • Dermatology
  • Clinical Case Study

Background:

  • Rosacea fulminans is a rare, severe variant of rosacea.
  • Characterized by abrupt onset of facial papules, pustules, and nodules.
  • Conventional treatments include systemic glucocorticoids and isotretinoin.

Observation:

  • A 56-year-old woman presented with a severe papulopustular facial eruption.
  • The eruption followed a period of significant seborrhoea.
  • Initial treatment with conventional therapies showed no significant improvement.

Findings:

  • Dapsone was administered as an alternative treatment.
  • Complete healing of the facial eruption was achieved within 5 weeks of dapsone therapy.
  • This suggests dapsone as a potential therapeutic option for refractory rosacea fulminans.

Related Experiment Videos

Implications:

  • Dapsone may be a viable treatment option for rosacea fulminans, especially in cases resistant to standard care.
  • This case expands treatment possibilities for this rare dermatological condition.
  • Further research into dapsone's efficacy and safety in rosacea fulminans is warranted.